266 related articles for article (PubMed ID: 28930661)
1. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.
Günther S; Deredge D; Bowers AL; Luchini A; Bonsor DA; Beadenkopf R; Liotta L; Wintrode PL; Sundberg EJ
Immunity; 2017 Sep; 47(3):510-523.e4. PubMed ID: 28930661
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
Front Immunol; 2021; 12():779100. PubMed ID: 35003094
[TBL] [Abstract][Full Text] [Related]
3. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex.
Casadio R; Frigimelica E; Bossù P; Neumann D; Martin MU; Tagliabue A; Boraschi D
FEBS Lett; 2001 Jun; 499(1-2):65-8. PubMed ID: 11418113
[TBL] [Abstract][Full Text] [Related]
4. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
Lingel A; Weiss TM; Niebuhr M; Pan B; Appleton BA; Wiesmann C; Bazan JF; Fairbrother WJ
Structure; 2009 Oct; 17(10):1398-410. PubMed ID: 19836339
[TBL] [Abstract][Full Text] [Related]
5. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.
Malinowsky D; Lundkvist J; Layé S; Bartfai T
FEBS Lett; 1998 Jun; 429(3):299-302. PubMed ID: 9662436
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
9. Structure-based Development of Human Interleukin-1β-Specific Antibody That Simultaneously Inhibits Binding to Both IL-1RI and IL-1RAcP.
Kuo WC; Lee CC; Chang YW; Pang W; Chen HS; Hou SC; Lo SY; Yang AS; Wang AH
J Mol Biol; 2021 Feb; 433(4):166766. PubMed ID: 33359099
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the interaction of IL-33 with its receptors.
Liu X; Hammel M; He Y; Tainer JA; Jeng US; Zhang L; Wang S; Wang X
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14918-23. PubMed ID: 23980170
[TBL] [Abstract][Full Text] [Related]
11. Effects of IL-1 receptor accessory protein on IL-1 binding.
Wesche H; Resch K; Martin MU
FEBS Lett; 1998 Jun; 429(3):303-6. PubMed ID: 9662437
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.
Touzani O; Boutin H; LeFeuvre R; Parker L; Miller A; Luheshi G; Rothwell N
J Neurosci; 2002 Jan; 22(1):38-43. PubMed ID: 11756486
[TBL] [Abstract][Full Text] [Related]
14. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
[TBL] [Abstract][Full Text] [Related]
15. The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.
Zarezadeh Mehrabadi A; Aghamohamadi N; Khoshmirsafa M; Aghamajidi A; Pilehforoshha M; Massoumi R; Falak R
Immunology; 2022 May; 166(1):38-46. PubMed ID: 35231129
[TBL] [Abstract][Full Text] [Related]
16. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
17. MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics.
Davis CN; Mann E; Behrens MM; Gaidarova S; Rebek M; Rebek J; Bartfai T
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2953-8. PubMed ID: 16477040
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
Zetterström M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
Eur Cytokine Netw; 1998 Jun; 9(2):131-8. PubMed ID: 9681388
[TBL] [Abstract][Full Text] [Related]
19. Human/mouse interleukin-1 receptor/receptor accessory protein interactions in IL-1beta-induced NFkappaB activation.
Layé S; Lundkvist J; Bartfai T
FEBS Lett; 1998 Jun; 429(3):307-11. PubMed ID: 9662438
[TBL] [Abstract][Full Text] [Related]
20. Functional Relevance of Interleukin-1 Receptor Inter-domain Flexibility for Cytokine Binding and Signaling.
Ge J; Remesh SG; Hammel M; Pan S; Mahan AD; Wang S; Wang X
Structure; 2019 Aug; 27(8):1296-1307.e5. PubMed ID: 31257107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
